$BTX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Lineage Cell Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Lineage Cell Therapeutics, Inc.. Get notifications about new insider transactions in Lineage Cell Therapeutics, Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 06 2021 | BTX | Lineage Cell Thera ... | Jayasuriya Anula | Director | Option Exercise | A | 2.58 | 90,000 | 232,200 | 90,000 | |
| Apr 22 2021 | BTX | Lineage Cell Thera ... | Amin Dipti | Director | Option Exercise | A | 2.28 | 90,000 | 205,200 | 90,000 | |
| Apr 01 2021 | BTX | Lineage Cell Thera ... | Hernandez Alexandra | Sr Director Finance ... | Option Exercise | M | 0.69 | 6,000 | 4,151 | 39,200 | |
| Apr 01 2021 | BTX | Lineage Cell Thera ... | Hernandez Alexandra | Sr Director Finance ... | Option Exercise | A | 2.43 | 42,700 | 103,761 | 42,700 | |
| Apr 01 2021 | BTX | Lineage Cell Thera ... | Hernandez Alexandra | Sr Director Finance ... | Sell | S | 2.23 | 6,000 | 13,380 | 0 | 6 K to 0 (-100.00 %) |
| Apr 01 2021 | BTX | Lineage Cell Thera ... | Hernandez Alexandra | Sr Director Finance ... | Buy | M | 0.69 | 6,000 | 4,151 | 6,000 | 0 to 6 K |
| Apr 01 2021 | BTX | Lineage Cell Thera ... | Culley Brian M | President and CEO | Option Exercise | M | 0.00 | 15,450 | 0 | 77,250 | |
| Apr 01 2021 | BTX | Lineage Cell Thera ... | Culley Brian M | President and CEO | Payment of Exercise | F | 2.35 | 5,343 | 12,556 | 195,709 | 201.1 K to 195.7 K (-2.66 %) |
| Apr 01 2021 | BTX | Lineage Cell Thera ... | Culley Brian M | President and CEO | Buy | M | 2.35 | 15,450 | 36,308 | 201,052 | 185.6 K to 201.1 K (+8.32 %) |
| Mar 17 2021 | BTX | Lineage Cell Thera ... | Culley Brian M | President and CEO | Option Exercise | A | 2.43 | 1,165,100 | 2,831,193 | 1,165,100 | |
| Mar 17 2021 | BTX | Lineage Cell Thera ... | Hogge Gary S. | SVP,Clinical & Medi ... | Option Exercise | A | 2.43 | 419,500 | 1,019,385 | 419,500 | |
| Dec 31 2020 | BTX | Lineage Cell Thera ... | Culley Brian M | President and CEO | Option Exercise | M | 0.00 | 15,450 | 0 | 92,700 | |
| Dec 31 2020 | BTX | Lineage Cell Thera ... | Culley Brian M | President and CEO | Payment of Exercise | F | 1.76 | 5,343 | 9,404 | 185,602 | 190.9 K to 185.6 K (-2.80 %) |
| Dec 31 2020 | BTX | Lineage Cell Thera ... | Culley Brian M | President and CEO | Buy | M | 1.76 | 15,450 | 27,192 | 190,945 | 175.5 K to 190.9 K (+8.80 %) |
| Jul 02 2020 | BTX | Lineage Cell Thera ... | BRADSHER NEAL C | Director | Option Exercise | A | 0.83 | 40,000 | 33,052 | 40,000 | |
| Jul 02 2020 | BTX | Lineage Cell Thera ... | Culley Brian M | President and CEO | Option Exercise | M | 0.00 | 15,450 | 0 | 123,600 | |
| Jul 02 2020 | BTX | Lineage Cell Thera ... | Culley Brian M | President and CEO | Payment of Exercise | F | 0.87 | 5,343 | 4,648 | 165,388 | 170.7 K to 165.4 K (-3.13 %) |
| Jul 02 2020 | BTX | Lineage Cell Thera ... | Culley Brian M | President and CEO | Buy | M | 0.87 | 15,450 | 13,442 | 170,731 | 155.3 K to 170.7 K (+9.95 %) |
| Jul 02 2020 | BTX | Lineage Cell Thera ... | Mulroy Michael H. | Director | Option Exercise | A | 0.83 | 40,000 | 33,052 | 40,000 | |
| Jul 02 2020 | BTX | Lineage Cell Thera ... | BAILEY DON M | Director | Option Exercise | A | 0.83 | 40,000 | 33,052 | 40,000 | |
| Jul 02 2020 | BTX | Lineage Cell Thera ... | ANDREWS DEBORAH J | Director | Option Exercise | A | 0.83 | 40,000 | 33,052 | 40,000 | |
| Jul 02 2020 | BTX | Lineage Cell Thera ... | Russell Angus C. | Director | Option Exercise | A | 0.83 | 40,000 | 33,052 | 40,000 | |
| Mar 31 2020 | BTX | Lineage Cell Thera ... | Culley Brian M | President and CEO | Option Exercise | M | 0.00 | 15,450 | 0 | 139,050 | |
| Mar 31 2020 | BTX | Lineage Cell Thera ... | Culley Brian M | President and CEO | Payment of Exercise | F | 0.83 | 5,343 | 4,425 | 155,281 | 160.6 K to 155.3 K (-3.33 %) |
| Mar 31 2020 | BTX | Lineage Cell Thera ... | Culley Brian M | President and CEO | Buy | M | 0.83 | 15,450 | 12,794 | 160,624 | 145.2 K to 160.6 K (+10.64 %) |
| Mar 19 2020 | BTX | Lineage Cell Thera ... | Roberts Brandi | CFO & SVP Finance | Option Exercise | A | 0.69 | 616,700 | 426,695 | 616,700 | |
| Mar 19 2020 | BTX | Lineage Cell Thera ... | Leavitt Chase C. | General Counsel/Sec ... | Option Exercise | A | 0.69 | 616,700 | 426,695 | 616,700 | |
| Mar 19 2020 | BTX | Lineage Cell Thera ... | Hogge Gary S. | SVP,Clinical & Medi ... | Option Exercise | A | 0.69 | 444,000 | 307,204 | 444,000 | |
| Mar 19 2020 | BTX | Lineage Cell Thera ... | Culley Brian M | President and CEO | Option Exercise | A | 0.69 | 1,233,300 | 853,320 | 1,233,300 | |
| Dec 31 2019 | BTX | Lineage Cell Thera ... | Culley Brian M | President and CEO | Option Exercise | M | 0.00 | 15,450 | 0 | 154,500 | |
| Dec 31 2019 | BTX | Lineage Cell Thera ... | Culley Brian M | President and CEO | Payment of Exercise | F | 0.89 | 5,343 | 4,755 | 145,174 | 150.5 K to 145.2 K (-3.55 %) |
| Dec 31 2019 | BTX | Lineage Cell Thera ... | Culley Brian M | President and CEO | Buy | M | 0.00 | 15,450 | 0 | 150,517 | 135.1 K to 150.5 K (+11.44 %) |
| Oct 01 2019 | BTX | Lineage Cell Thera ... | Culley Brian M | President and CEO | Option Exercise | M | 0.00 | 15,450 | 0 | 169,950 | |
| Oct 01 2019 | BTX | Lineage Cell Thera ... | Culley Brian M | President and CEO | Payment of Exercise | F | 0.98 | 5,343 | 5,236 | 135,067 | 140.4 K to 135.1 K (-3.81 %) |
| Oct 01 2019 | BTX | Lineage Cell Thera ... | Culley Brian M | President and CEO | Buy | M | 0.00 | 15,450 | 0 | 140,410 | 125 K to 140.4 K (+12.36 %) |
| Sep 19 2019 | BTX | Lineage Cell Thera ... | Culley Brian M | President and CEO | Option Exercise | M | 0.00 | 61,800 | 0 | 185,400 | |
| Sep 19 2019 | BTX | Lineage Cell Thera ... | Culley Brian M | President and CEO | Payment of Exercise | F | 1.00 | 21,371 | 21,371 | 124,960 | 146.3 K to 125 K (-14.60 %) |
| Sep 19 2019 | BTX | Lineage Cell Thera ... | Culley Brian M | President and CEO | Buy | M | 0.00 | 61,800 | 0 | 146,331 | 84.5 K to 146.3 K (+73.11 %) |
| Sep 13 2019 | BTX | Lineage Cell Thera ... | Lineage Cell Therapeutics, Inc ... | 10% Owner | Sell | S | 1.66 | 4,000,000 | 6,640,000 | 8,424,244 | 12.4 M to 8.4 M (-32.20 %) |
| Aug 15 2019 | BTX | Lineage Cell Thera ... | BROADWOOD PARTNERS, L.P. | Director | Buy | P | 0.97 | 13,146 | 12,717 | 34,005,379 | 34 M to 34 M (+0.04 %) |
| Aug 15 2019 | BTX | Lineage Cell Thera ... | BROADWOOD PARTNERS, L.P. | Director | Buy | P | 0.98 | 1,407 | 1,379 | 33,992,233 | 34 M to 34 M (0.00 %) |
| Aug 15 2019 | BTX | Lineage Cell Thera ... | BROADWOOD PARTNERS, L.P. | Director | Buy | P | 0.99 | 10,000 | 9,949 | 33,990,826 | 34 M to 34 M (+0.03 %) |
| Aug 15 2019 | BTX | Lineage Cell Thera ... | Leavitt Chase C. | General Counsel/Sec ... | Option Exercise | A | 1.10 | 125,000 | 137,500 | 125,000 | |
| Aug 15 2019 | BTX | Lineage Cell Thera ... | Leavitt Chase C. | General Counsel/Sec ... | Buy | P | 1.02 | 5,000 | 5,100 | 5,000 | 0 to 5 K |
| Aug 15 2019 | BTX | Lineage Cell Thera ... | Roberts Brandi | CFO & SVP, Finance | Buy | P | 1.01 | 5,000 | 5,050 | 5,000 | 0 to 5 K |
| Aug 15 2019 | BTX | Lineage Cell Thera ... | Culley Brian M | President and CEO | Buy | P | 1.01 | 10,000 | 10,100 | 84,531 | 74.5 K to 84.5 K (+13.42 %) |
| Jul 05 2019 | BTX | BIOTIME INC | BIOTIME INC | 10% Owner | Sell | S | 2.00 | 2,250,000 | 4,500,000 | 12,424,244 | 14.7 M to 12.4 M (-15.33 %) |
| Jul 03 2019 | BTX | BIOTIME INC | ANDREWS DEBORAH J | Director | Option Exercise | A | 1.03 | 40,000 | 41,200 | 40,000 | |
| Jul 03 2019 | BTX | BIOTIME INC | BAILEY DON M | Director | Option Exercise | A | 1.57 | 60,000 | 94,200 | 60,000 | |
| Jul 03 2019 | BTX | BIOTIME INC | BAILEY DON M | Director | Option Exercise | A | 1.03 | 40,000 | 41,200 | 40,000 | |
| Jul 03 2019 | BTX | BIOTIME INC | FARRELL STEPHEN C | Director | Option Exercise | A | 1.03 | 40,000 | 41,200 | 40,000 | |
| Jul 03 2019 | BTX | BIOTIME INC | KINGSLEY ALFRED D | Director | Option Exercise | A | 1.03 | 70,000 | 72,100 | 70,000 | |
| Jul 03 2019 | BTX | BIOTIME INC | Mulroy Michael H. | Director | Option Exercise | A | 1.03 | 40,000 | 41,200 | 40,000 | |
| Jul 03 2019 | BTX | BIOTIME INC | Russell Angus C. | Director | Option Exercise | A | 1.03 | 40,000 | 41,200 | 40,000 | |
| Jul 03 2019 | BTX | BIOTIME INC | BRADSHER NEAL C | Director | Option Exercise | A | 1.03 | 40,000 | 41,200 | 40,000 | |
| Jul 02 2019 | BTX | BIOTIME INC | Roberts Brandi | CFO & SVP, Finance | Option Exercise | A | 1.10 | 150,000 | 165,000 | 150,000 | |
| May 22 2019 | BTX | BIOTIME INC | Leavitt Chase C. | General Counsel/Sec ... | Option Exercise | A | 1.13 | 300,000 | 339,000 | 300,000 | |
| Apr 18 2019 | BTX | BIOTIME INC | BROADWOOD PARTNERS, L.P. | Director | Buy | J | 1.32 | 251,835 | 332,397 | 33,980,826 | 33.7 M to 34 M (+0.75 %) |
| Apr 05 2019 | BTX | BIOTIME INC | KINGSLEY ALFRED D | Director | Grant | A | 0.00 | 6,390 | 0 | 5,457,945 | 5.5 M to 5.5 M (+0.12 %) |
| Mar 21 2019 | BTX | BIOTIME INC | Wirth Edward | Chief Medical Offic ... | Option Exercise | A | 1.57 | 350,000 | 549,500 | 350,000 | |
| Mar 15 2019 | BTX | BIOTIME INC | Mulroy Michael H. | Director | Grant | A | 0.00 | 194,271 | 0 | 226,821 | 32.6 K to 226.8 K (+596.84 %) |
| Mar 15 2019 | BTX | BIOTIME INC | Mulroy Michael H. | Director | Grant | A | 0.00 | 194,271 | 0 | 226,821 | 32.6 K to 226.8 K (+596.84 %) |
| Mar 12 2019 | BTX | BIOTIME INC | BROADWOOD PARTNERS, L.P. | Director | Buy | J | 0.00 | 3,757,430 | 0 | 33,728,991 | 30 M to 33.7 M (+12.54 %) |
| Jan 09 2019 | BTX | BIOTIME INC | Roberts Brandi | CFO & SVP, Finance | Option Exercise | A | 1.08 | 500,000 | 540,000 | 500,000 | |
| Jan 03 2019 | BTX | BIOTIME INC | Culley Brian M | President and CEO | Option Exercise | M | 0.00 | 100,000 | 0 | 0 | |
| Jan 03 2019 | BTX | BIOTIME INC | Culley Brian M | President and CEO | Payment of Exercise | F | 0.91 | 40,880 | 37,323 | 59,120 | 100 K to 59.1 K (-40.88 %) |
| Jan 03 2019 | BTX | BIOTIME INC | Culley Brian M | President and CEO | Buy | M | 0.00 | 100,000 | 0 | 100,000 | 0 to 100 K |
| Dec 20 2018 | BTX | BIOTIME INC | SKIBSTED RUSSELL | Chief Financial Off ... | Option Exercise | M | 0.00 | 22,500 | 0 | 11,250 | |
| Dec 20 2018 | BTX | BIOTIME INC | SKIBSTED RUSSELL | Chief Financial Off ... | Payment of Exercise | F | 1.03 | 7,781 | 8,014 | 24,078 | 31.9 K to 24.1 K (-24.42 %) |
| Dec 20 2018 | BTX | BIOTIME INC | SKIBSTED RUSSELL | Chief Financial Off ... | Buy | M | 0.00 | 22,500 | 0 | 31,859 | 9.4 K to 31.9 K (+240.41 %) |
| Dec 20 2018 | BTX | BIOTIME INC | SKIBSTED RUSSELL | Chief Financial Off ... | Option Exercise | M | 0.00 | 22,500 | 0 | 11,250 | |
| Dec 20 2018 | BTX | BIOTIME INC | SKIBSTED RUSSELL | Chief Financial Off ... | Payment of Exercise | F | 1.03 | 7,781 | 8,014 | 24,078 | 31.9 K to 24.1 K (-24.42 %) |
| Dec 20 2018 | BTX | BIOTIME INC | SKIBSTED RUSSELL | Chief Financial Off ... | Buy | M | 0.00 | 22,500 | 0 | 31,859 | 9.4 K to 31.9 K (+240.41 %) |
| Dec 20 2018 | BTX | BIOTIME INC | Patton Stephana Eilene | General Counsel & S ... | Option Exercise | M | 0.00 | 27,500 | 0 | 13,750 | |
| Dec 20 2018 | BTX | BIOTIME INC | Patton Stephana Eilene | General Counsel & S ... | Payment of Exercise | F | 1.03 | 9,510 | 9,795 | 34,485 | 44 K to 34.5 K (-21.62 %) |
| Dec 20 2018 | BTX | BIOTIME INC | Patton Stephana Eilene | General Counsel & S ... | Buy | M | 0.00 | 27,500 | 0 | 43,995 | 16.5 K to 44 K (+166.72 %) |
| Oct 09 2018 | BTX | BIOTIME INC | Patton Stephana Eilene | General Counsel & S ... | Option Exercise | M | 0.00 | 13,750 | 0 | 41,250 | |
| Oct 09 2018 | BTX | BIOTIME INC | Patton Stephana Eilene | General Counsel & S ... | Payment of Exercise | F | 2.22 | 4,755 | 10,556 | 16,495 | 21.3 K to 16.5 K (-22.38 %) |
| Oct 09 2018 | BTX | BIOTIME INC | Patton Stephana Eilene | General Counsel & S ... | Buy | M | 0.00 | 13,750 | 0 | 21,250 | 7.5 K to 21.3 K (+183.33 %) |
| Oct 09 2018 | BTX | BIOTIME INC | SKIBSTED RUSSELL | Chief Financial Off ... | Option Exercise | M | 0.00 | 11,250 | 0 | 33,750 | |
| Oct 09 2018 | BTX | BIOTIME INC | SKIBSTED RUSSELL | Chief Financial Off ... | Option Exercise | M | 0.00 | 11,250 | 0 | 33,750 | |
| Oct 09 2018 | BTX | BIOTIME INC | SKIBSTED RUSSELL | Chief Financial Off ... | Payment of Exercise | F | 2.22 | 3,891 | 8,638 | 9,359 | 13.3 K to 9.4 K (-29.37 %) |
| Oct 09 2018 | BTX | BIOTIME INC | SKIBSTED RUSSELL | Chief Financial Off ... | Payment of Exercise | F | 2.22 | 3,891 | 8,638 | 9,359 | 13.3 K to 9.4 K (-29.37 %) |
| Oct 09 2018 | BTX | BIOTIME INC | SKIBSTED RUSSELL | Chief Financial Off ... | Buy | M | 0.00 | 11,250 | 0 | 13,250 | 2 K to 13.3 K (+562.50 %) |
| Oct 09 2018 | BTX | BIOTIME INC | SKIBSTED RUSSELL | Chief Financial Off ... | Buy | M | 0.00 | 11,250 | 0 | 13,250 | 2 K to 13.3 K (+562.50 %) |
| Sep 19 2018 | BTX | BIOTIME INC | WEST MICHAEL D | Co-Chief Executive ... | Option Exercise | M | 0.00 | 10,938 | 0 | 0 | |
| Sep 19 2018 | BTX | BIOTIME INC | WEST MICHAEL D | Co-Chief Executive ... | Option Exercise | M | 0.00 | 10,938 | 0 | 0 | |
| Sep 19 2018 | BTX | BIOTIME INC | WEST MICHAEL D | Co-Chief Executive ... | Payment of Exercise | F | 2.31 | 3,783 | 8,739 | 893,913 | 897.7 K to 893.9 K (-0.42 %) |
| Sep 19 2018 | BTX | BIOTIME INC | WEST MICHAEL D | Co-Chief Executive ... | Payment of Exercise | F | 2.31 | 3,783 | 8,739 | 893,913 | 897.7 K to 893.9 K (-0.42 %) |
| Sep 19 2018 | BTX | BIOTIME INC | WEST MICHAEL D | Co-Chief Executive ... | Buy | M | 0.00 | 10,938 | 0 | 897,696 | 886.8 K to 897.7 K (+1.23 %) |
| Sep 19 2018 | BTX | BIOTIME INC | WEST MICHAEL D | Co-Chief Executive ... | Buy | M | 0.00 | 10,938 | 0 | 897,696 | 886.8 K to 897.7 K (+1.23 %) |
| Sep 19 2018 | BTX | BIOTIME INC | Culley Brian M | President and CEO | Option Exercise | A | 0.00 | 100,000 | 0 | 100,000 | |
| Sep 19 2018 | BTX | BIOTIME INC | Culley Brian M | President and CEO | Option Exercise | A | 0.00 | 100,000 | 0 | 100,000 | |
| Sep 19 2018 | BTX | BIOTIME INC | Culley Brian M | President and CEO | Option Exercise | A | 0.00 | 200,000 | 0 | 200,000 | |
| Sep 19 2018 | BTX | BIOTIME INC | Culley Brian M | President and CEO | Option Exercise | A | 0.00 | 200,000 | 0 | 200,000 | |
| Sep 19 2018 | BTX | BIOTIME INC | Culley Brian M | President and CEO | Option Exercise | A | 2.31 | 1,500,000 | 3,465,000 | 1,500,000 | |
| Sep 19 2018 | BTX | BIOTIME INC | Culley Brian M | President and CEO | Option Exercise | A | 2.31 | 1,500,000 | 3,465,000 | 1,500,000 | |
| Sep 13 2018 | BTX | BIOTIME INC | ANDREWS DEBORAH J | Director | Buy | P | 2.35 | 1,604 | 3,769 | 10,000 | 8.4 K to 10 K (+19.10 %) |
| Jul 12 2018 | BTX | BIOTIME INC | WEST MICHAEL D | Co-Chief Executive ... | Option Exercise | M | 0.00 | 1,562 | 0 | 10,938 | |
| Jul 12 2018 | BTX | BIOTIME INC | WEST MICHAEL D | Co-Chief Executive ... | Payment of Exercise | F | 2.20 | 541 | 1,190 | 886,758 | 887.3 K to 886.8 K (-0.06 %) |
| Jul 12 2018 | BTX | BIOTIME INC | WEST MICHAEL D | Co-Chief Executive ... | Buy | M | 0.00 | 1,562 | 0 | 887,299 | 885.7 K to 887.3 K (+0.18 %) |
| Jul 12 2018 | BTX | BIOTIME INC | MOHANTY ADITYA P. | Co-Chief Executive ... | Option Exercise | M | 0.00 | 4,687 | 0 | 32,813 | |
| Jul 12 2018 | BTX | BIOTIME INC | MOHANTY ADITYA P. | Co-Chief Executive ... | Payment of Exercise | F | 2.20 | 1,621 | 3,566 | 101,384 | 103 K to 101.4 K (-1.57 %) |
| Jul 12 2018 | BTX | BIOTIME INC | MOHANTY ADITYA P. | Co-Chief Executive ... | Buy | M | 0.00 | 4,687 | 0 | 103,005 | 98.3 K to 103 K (+4.77 %) |
| Jul 12 2018 | BTX | BIOTIME INC | WEST MICHAEL D | Co-Chief Executive ... | Option Exercise | M | 0.00 | 1,562 | 0 | 10,938 | |
| Jul 12 2018 | BTX | BIOTIME INC | WEST MICHAEL D | Co-Chief Executive ... | Payment of Exercise | F | 2.20 | 541 | 1,190 | 886,758 | 887.3 K to 886.8 K (-0.06 %) |
| Jul 12 2018 | BTX | BIOTIME INC | WEST MICHAEL D | Co-Chief Executive ... | Buy | M | 0.00 | 1,562 | 0 | 887,299 | 885.7 K to 887.3 K (+0.18 %) |
| Jul 12 2018 | BTX | BIOTIME INC | MOHANTY ADITYA P. | Co-Chief Executive ... | Option Exercise | M | 0.00 | 4,687 | 0 | 32,813 | |
| Jul 12 2018 | BTX | BIOTIME INC | MOHANTY ADITYA P. | Co-Chief Executive ... | Payment of Exercise | F | 2.20 | 1,621 | 3,566 | 101,384 | 103 K to 101.4 K (-1.57 %) |
| Jul 12 2018 | BTX | BIOTIME INC | MOHANTY ADITYA P. | Co-Chief Executive ... | Buy | M | 0.00 | 4,687 | 0 | 103,005 | 98.3 K to 103 K (+4.77 %) |
| Jul 03 2018 | BTX | BIOTIME INC | KINGSLEY ALFRED D | See Remarks | Option Exercise | A | 2.06 | 70,000 | 144,200 | 70,000 | |
| Jul 03 2018 | BTX | BIOTIME INC | Russell Angus C. | Director | Option Exercise | A | 2.06 | 40,000 | 82,400 | 40,000 | |
| Jul 03 2018 | BTX | BIOTIME INC | Redmond Cavan M. | Director | Option Exercise | A | 2.06 | 40,000 | 82,400 | 40,000 | |
| Jul 03 2018 | BTX | BIOTIME INC | Mulroy Michael H. | Director | Option Exercise | A | 2.06 | 40,000 | 82,400 | 40,000 | |
| Jul 03 2018 | BTX | BIOTIME INC | FARRELL STEPHEN C | Director | Option Exercise | A | 2.06 | 40,000 | 82,400 | 40,000 | |
| Jul 03 2018 | BTX | BIOTIME INC | ANDREWS DEBORAH J | Director | Option Exercise | A | 2.06 | 40,000 | 82,400 | 40,000 | |
| Jul 03 2018 | BTX | BIOTIME INC | BRADSHER NEAL C | Director | Option Exercise | A | 2.06 | 40,000 | 82,400 | 40,000 | |
| Apr 12 2018 | BTX | BIOTIME INC | WEST MICHAEL D | Co-Chief Executive ... | Option Exercise | M | 0.00 | 1,563 | 0 | 12,500 | |
| Apr 12 2018 | BTX | BIOTIME INC | WEST MICHAEL D | Co-Chief Executive ... | Payment of Exercise | F | 2.49 | 541 | 1,347 | 885,737 | 886.3 K to 885.7 K (-0.06 %) |
| Apr 12 2018 | BTX | BIOTIME INC | WEST MICHAEL D | Co-Chief Executive ... | Buy | M | 0.00 | 1,563 | 0 | 886,278 | 884.7 K to 886.3 K (+0.18 %) |
| Apr 12 2018 | BTX | BIOTIME INC | MOHANTY ADITYA P. | Co-Chief Executive ... | Option Exercise | M | 0.00 | 4,688 | 0 | 37,500 | |
| Apr 12 2018 | BTX | BIOTIME INC | MOHANTY ADITYA P. | Co-Chief Executive ... | Payment of Exercise | F | 2.49 | 1,622 | 4,039 | 98,318 | 99.9 K to 98.3 K (-1.62 %) |
| Apr 12 2018 | BTX | BIOTIME INC | MOHANTY ADITYA P. | Co-Chief Executive ... | Buy | M | 0.00 | 4,688 | 0 | 99,940 | 95.3 K to 99.9 K (+4.92 %) |
| Mar 19 2018 | BTX | BIOTIME INC | Patton Stephana Eilene | General Counsel & S ... | Option Exercise | A | 2.54 | 125,000 | 317,500 | 125,000 | |
| Mar 19 2018 | BTX | BIOTIME INC | SKIBSTED RUSSELL | Chief Financial Off ... | Option Exercise | A | 2.54 | 150,000 | 381,000 | 150,000 | |
| Mar 19 2018 | BTX | BIOTIME INC | MOHANTY ADITYA P. | Co-Chief Executive ... | Option Exercise | A | 2.54 | 200,000 | 508,000 | 200,000 | |
| Jan 12 2018 | BTX | BIOTIME INC | MOHANTY ADITYA P. | Co-Chief Executive ... | Option Exercise | M | 0.00 | 4,687 | 0 | 42,188 | |
| Jan 12 2018 | BTX | BIOTIME INC | MOHANTY ADITYA P. | Co-Chief Executive ... | Payment of Exercise | F | 2.68 | 2,057 | 5,513 | 95,252 | 97.3 K to 95.3 K (-2.11 %) |
| Jan 12 2018 | BTX | BIOTIME INC | MOHANTY ADITYA P. | Co-Chief Executive ... | Buy | M | 0.00 | 4,687 | 0 | 97,309 | 92.6 K to 97.3 K (+5.06 %) |
| Jan 12 2018 | BTX | BIOTIME INC | WEST MICHAEL D | Co-Chief Executive ... | Option Exercise | M | 0.00 | 1,562 | 0 | 14,063 | |
| Jan 12 2018 | BTX | BIOTIME INC | WEST MICHAEL D | Co-Chief Executive ... | Payment of Exercise | F | 2.68 | 686 | 1,838 | 884,715 | 885.4 K to 884.7 K (-0.08 %) |
| Jan 12 2018 | BTX | BIOTIME INC | WEST MICHAEL D | Co-Chief Executive ... | Buy | M | 0.00 | 1,562 | 0 | 885,401 | 883.8 K to 885.4 K (+0.18 %) |
| Oct 17 2017 | BTX | BIOTIME INC | BROADWOOD PARTNERS, L.P. | Director | Buy | P | 2.60 | 2,692,307 | 6,999,998 | 29,971,561 | 27.3 M to 30 M (+9.87 %) |
| Oct 12 2017 | BTX | BIOTIME INC | MOHANTY ADITYA P. | Co-Chief Executive ... | Option Exercise | M | 0.00 | 4,688 | 0 | 46,875 | |
| Oct 12 2017 | BTX | BIOTIME INC | MOHANTY ADITYA P. | Co-Chief Executive ... | Payment of Exercise | F | 2.81 | 1,762 | 4,951 | 92,622 | 94.4 K to 92.6 K (-1.87 %) |
| Oct 12 2017 | BTX | BIOTIME INC | MOHANTY ADITYA P. | Co-Chief Executive ... | Buy | M | 0.00 | 4,688 | 0 | 94,384 | 89.7 K to 94.4 K (+5.23 %) |
| Oct 12 2017 | BTX | BIOTIME INC | WEST MICHAEL D | Co-Chief Executive ... | Option Exercise | M | 0.00 | 1,563 | 0 | 15,625 | |
| Oct 12 2017 | BTX | BIOTIME INC | WEST MICHAEL D | Co-Chief Executive ... | Payment of Exercise | F | 2.81 | 588 | 1,652 | 883,839 | 884.4 K to 883.8 K (-0.07 %) |
| Oct 12 2017 | BTX | BIOTIME INC | WEST MICHAEL D | Co-Chief Executive ... | Buy | M | 0.00 | 1,563 | 0 | 884,427 | 882.9 K to 884.4 K (+0.18 %) |
| Aug 25 2017 | BTX | BIOTIME INC | SKIBSTED RUSSELL | Chief Financial Off ... | Buy | P | 2.64 | 2,000 | 5,285 | 2,000 | 0 to 2 K |
| Aug 24 2017 | BTX | BIOTIME INC | BROADWOOD PARTNERS, L.P. | Director | Buy | P | 2.60 | 10,000 | 25,955 | 27,279,254 | 27.3 M to 27.3 M (+0.04 %) |
| Aug 23 2017 | BTX | BIOTIME INC | WEST MICHAEL D | Co-Chief Executive ... | Buy | P | 2.60 | 2,000 | 5,198 | 882,864 | 880.9 K to 882.9 K (+0.23 %) |
| Aug 23 2017 | BTX | BIOTIME INC | ANDREWS DEBORAH J | Director | Buy | P | 2.50 | 2,396 | 5,990 | 8,396 | 6 K to 8.4 K (+39.93 %) |
| Aug 22 2017 | BTX | BIOTIME INC | Patton Stephana Eilene | General Counsel | Buy | P | 2.58 | 7,500 | 19,376 | 7,500 | 0 to 7.5 K |
| Aug 22 2017 | BTX | BIOTIME INC | MOHANTY ADITYA P. | Co-Chief Executive ... | Buy | P | 2.50 | 7,500 | 18,750 | 89,696 | 82.2 K to 89.7 K (+9.12 %) |
| Aug 21 2017 | BTX | BIOTIME INC | KINGSLEY ALFRED D | See Remarks | Sell | D | 2.81 | 300,000 | 843,000 | 5,481,555 | 5.8 M to 5.5 M (-5.19 %) |
| Aug 02 2017 | BTX | BIOTIME INC | BROADWOOD PARTNERS, L.P. | Director | Buy | P | 2.80 | 150,000 | 420,000 | 27,269,254 | 27.1 M to 27.3 M (+0.55 %) |
| Aug 02 2017 | BTX | BIOTIME INC | KINGSLEY ALFRED D | See Remarks | Sell | S | 2.80 | 150,000 | 420,000 | 5,781,555 | 5.9 M to 5.8 M (-2.53 %) |
| Jul 12 2017 | BTX | BIOTIME INC | WEST MICHAEL D | Co-Chief Executive ... | Option Exercise | M | 0.00 | 1,562 | 0 | 17,188 | |
| Jul 12 2017 | BTX | BIOTIME INC | WEST MICHAEL D | Co-Chief Executive ... | Payment of Exercise | F | 3.09 | 587 | 1,814 | 880,864 | 881.5 K to 880.9 K (-0.07 %) |